<DOC>
	<DOCNO>NCT02691312</DOCNO>
	<brief_summary>Diabetic retinopathy ( DR ) cause new case blindness among young adult disease . More 90 % individual type 1 diabetes ( T1D ) form DR 20 year diagnosis . DR associate long-term hyperglycemia blood glucose variability , induces vascular endothelial dysfunction destruction retina , eventual retinal ischemia , end , widespread neovascularization retina optic disk . When fragile vessel bleed , cause vitreous hemorrhage loss vision . Eventually friable vessel fibrose result retinal detachment retinal ischemia . Major risk factor development diabetic retinopathy time since diagnosis , age diagnosis , severity hyperglycemia . Retinopathy commonly occur least three year diagnosis case diagnose five year onset T1D . Current guideline American Diabetes Association ( ADA ) American Academy Ophthalmology ( AAO ) recommend patient T1D undergo initial comprehensive dilate fundoscopic evaluation individual diabetes 3-5 year either reach puberty 10 year age , whichever early . These patient receive yearly exam thereafter , every two year base upon recommendation eye care professional . However , prevalence retinopathy child unknown adherence guideline , especially youth , proven difficult . Thus , important make guideline evidence base , retinopathy often asymptomatic vision loss occur . The first step process determination prevalence retinopathy general population youth diabetes . This follow determine child risk , guideline provide realistic pertinent guidance practitioner .</brief_summary>
	<brief_title>Pediatric Type 1 Diabetes Retinopathy</brief_title>
	<detailed_description>The study prospective cross-sectional study pediatric participant T1D one year . Pediatric participant recruit Florida Diabetes Camps , Children With Diabetes Friends Life Orlando Conference , University Florida Pediatric Endocrinology Clinics . The participant test diabetic retinopathy use Digital Retinography System ( DRS ) ( http : //www.centervue.com/producta556.html ? id=637 ) . The DRS portable non-mydriatic fundus camera participant place chin chin-rest device take digital image eye evaluation ophthalmologist remotely . These photograph examine ophthalmologist ( specialize retinal disease ) ass evidence diabetic retinopathy . As part inform consent , participant ask part inform consent allow study staff contact local ophthalmologist eye exam result follow positive inconclusive portable retinal screening . Participants guardian also ask fill study questionnaire screen visit . When available , study subject ' medical record access identify BMI , time since T1D diagnosis , previous hemoglobin A1c ( HbA1c ) level last 12 month ( longer available ) , insulin regimen , Tanner staging , serum lipid , urine microalbumin : creatinine , presence absence hypertension , previous diagnosis diabetic retinopathy , microalbuminuria , hyperlipidemia hypertension .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>Diagnosis type 1 diabetes Duration diabetes 1 year great Diabetes less 1 year duration Age &lt; 9 year &gt; 26 year age</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>type 1 diabetes</keyword>
	<keyword>retinopathy</keyword>
</DOC>